Skip to main content
NCBI home page
Atencion Primaria logoLink to Atencion Primaria
. 2013 Apr 5;31(7):428–432. [Article in Spanish] doi: 10.1016/S0212-6567(03)79202-6

Estudio epidemiológico del virus de la hepatitis C en nuestra población y cobertura vacunal

Epidemiological Study of the Hepatitis C Virus In our Population and Vaccine Coverage

MA Martínez Adell 1,*, A Vives Argilagós 1, FX Sibera Aresté 1, P Navarrete Durán 1, S Barro Lugo 1, P Urbina García 1
PMCID: PMC7679762  PMID: 12735885

Abstract

Objective

Epidemiological study of patients with chronic hepatitis C and its serological status in relation to the hepatitis A (HA) and B (HB) viruses.

Design

Descriptive cross-sectional study.

Setting

Two urban health centres.

Participants

291 patients with chronic hepatitis C.

Main measurements

Variables: age, sex, year and reason for diagnosis, personal histories, alcohol intake, serological status of the HA and HB viruses and HIV, and initial level of transaminases.

Results

Mean age, 55±16. Sex, 52% women. Prevalence, 0.98%. Reason for diagnosis, 41% health study, 15% study of hepatic pathology, 18% study of other pathologies. Personal histories, surgical intervention, 37.5%; intravenous drug users, 21.4%; transfusion, 14%; high-risk sexual conduct, 2.4%; health material used more than once, 2.4%; family member HC positive, 1.4%; no personal history recorded, 26.5%. Alcoholism, 17.9%. Mean transaminases: AST, 79.7±100 (9–920); ALT, 114.8±160 (6–1640). HB serological status: natural immunity, 22%; chronic, 9%; vaccine immunity, 3%; negative, 44%; not recorded, 21%. HA serological status: natural immunity, 2%; vaccine immunity, 2.5%; negative, 9%; not recorded, 87%. HIV-positive: 4.5%.

Conclusions

Prevalence was below the expected level. Knowledge of serological status needs to be improved, especially for HA. The degree of vaccine coverage in these patients for HA and HB should be increased.

Key words: Epidemiology, Chronic hepatitis C, Hepatitis A, Hepatitis B, Primary care

Footnotes

Este trabajo recibió el Premi a la Millora de l’Atenció Primária de Salut de L’Hospitalet (1.a edición, 1999), como proyecto.

Bibliografía

  • 1.Alter M.J., Kruszon-Moran D., Nainan O.V., McQuilan G.M., Fengxiang G., Moyer L.A. The prevalence of hepatitis c virus infection in the United States, 1988 through 1994. N Engl J Med. 1999;341:556–562. doi: 10.1056/NEJM199908193410802. [DOI] [PubMed] [Google Scholar]
  • 2.López Expósito F., Massagué Camins C., Cano Romera A., López Plana A., Espona Banis R., López Martínez R. Estudio de la prevalencia de infección por el virus de la hepatitis C y estudio de contactos convivientes. Aten Primaria. 1998;21:229–232. [PubMed] [Google Scholar]
  • 3.Prevenció i control de l’hepatitis C als centres sanitaris Col·lecció Recomanacions per a la prevenció de la infecció als centres sanitaris. Generalitat de Catalunya. Departament de Salut i Seguretat Social. 1999;8:11. [Google Scholar]
  • 4.Vento S., Garofano T., Renzini C., Cainelli F., Casali F., Ghironzi G. Fulminant hepatitis associated with hepatitis A superinfection in patients with chronic hepatitis C. N Engl J Med. 1998:338. doi: 10.1056/NEJM199801293380503. [DOI] [PubMed] [Google Scholar]
  • 5.Jain A., Kar P., Madan K., Das U.P., Budhiraja S., Gopalknishna V. Hepatitis C virus infection in sporadic fulminant viral hepatitis in North India: cause or cofactor? Eur J Gastroenterol Hepatol. 1999;11:1231–1237. doi: 10.1097/00042737-199911000-00008. [DOI] [PubMed] [Google Scholar]
  • 6.Chu C.M., Yeh C.T., Liaw Y.F. Fulminant hepatic failure in acute hepatitis C: increased risk in chronics carriers of hepatitis B virus. Gut. 1999;45:613–617. doi: 10.1136/gut.45.4.613. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Córdova García R., Ortega Sánchez-Pinilla R., Cabezas Peña C., Forés García D., Nebot Adell M. Recomendaciones sobre el estilo de vida. Aten Primaria. 1999;24(Supl 1):118–132. [PubMed] [Google Scholar]
  • 8.Sacristán B., Gatañores M.J., Elena A., Sacristán M., Barcenilla J., García J.C. Infección por el virus de la hepatitis C. Estudio seroepidemiológico en población general de La Rioja. Med Clin (Barc) 1996;107:331–335. [PubMed] [Google Scholar]
  • 9.Miquel A., González J.J., Moreno E., Gómez E., Sánchez A., Cirujano F. Hepatitis C en atención primaria: estudio de los portadores y sus familiares. Aten Primaria. 1994;13:16–19. [PubMed] [Google Scholar]
  • 10.Guia per a la prevenció i el control de l’hepatitis C. Quaderns de Salut Pública 13. Generalitat de Catalunya. Departament de Sanitat i Seguretat Social. 1999;3:30. [Google Scholar]
  • 11.Generalitat de Catalunya Departament de Sanitat i Seguretat Social. Butlletí Epidemiológic de Catalunya. 1993 XIV (número extraordinario) [Google Scholar]
  • 12.Generalitat de Catalunya Departament de Sanitat i Seguretat Social. Butlletí Epidemiológic de Catalunya. 1994 XV (número extraordinario) [Google Scholar]
  • 13.Generalitat de Catalunya Departament de Sanitat i Seguretat Social. Butlletí Epidemiológic de Catalunya. 1995 XVI (número extraordinario) [Google Scholar]
  • 14.Generalitat de Catalunya Departament de Sanitat i Seguretat Social. Butlletí Epidemiológic de Catalunya. 1996 XVII (extraordinario 2.° trimestre) [Google Scholar]
  • 15.Generalitat de Catalunya Departament de Sanitat i Seguretat Social. Butlletí Epidemiológic de Catalunya. 1997 XVIII (extraordinario 2.° trimestre) [Google Scholar]
  • 16.Centers for Disease Control. Prevention Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR. 1998;47(RR19):1–39. [Google Scholar]
  • 17.Kiefer L.A., Honish A., Predy G., Talbot J.A. The seroprevalence of hepatitis A and B in people testing positive for hepatitis C. Can Med A J. 2000;2:162. [PMC free article] [PubMed] [Google Scholar]
  • 18.Olivé G., Buti M., Esteban J.I., Cotrina M., Esteban R., Guardia J. Prevalencia e incidencia de la infección por el virus de la hepatitis A en pacientes con hepatitis B y C. Med Clin (Barc) 2000;115:254–255. doi: 10.1016/s0025-7753(00)71525-9. [DOI] [PubMed] [Google Scholar]
  • 19.Allwright S., Bradley F., Long J., Barry J., Thornton L., Parry J. Prevalence of antibodies to hepatitis B, hepatitis C, and HIV and risk factors in Irish prisioners: results of a national cross sectional survey. BMJ. 2000;321:78–82. doi: 10.1136/bmj.321.7253.78. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Guia per a la prevenció i el control de l’hepatitis C. Quaderns de Salut Pública 13. Generalitat de Catalunya. Departament de Sanitat i Seguretat Social. 1999;5:42. [Google Scholar]
  • 21.National Institutes of Health. Management of hepatitis C. National Institutes of Health consensus development conference statement 105 (1997 Mar 24–26). [Consultado el 23 de diciembre de 1999]. Disponible en: http://text.nhlm.nih.gov/nih/cdc/www/105.html
  • 22.Tamai T., Seki T., Shiro T., Nakagawa T., Wakabayashi M., Imamura M. Effects of alcohol consumption on histological changes in chronic hepatitis C: a clinicopatholoical study. Alcohol Clin Exp Res. 2000;24(Suppl 4):S106–111. [PubMed] [Google Scholar]

Articles from Atencion Primaria are provided here courtesy of Elsevier

RESOURCES